Genetics of Pulmonary Pressure and Right Ventricle Stress Identify Diabetes as a Causal Risk Factor
Open Access
- 1 August 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (15) , e029190
Abstract
Background: Epidemiologic studies have identified risk factors associated with pulmonary hypertension and right heart failure, but causative drivers of pulmonary hypertension and right heart adaptation are not well known. We sought to leverage unbiased genetic approaches to determine clinical conditions that share genetic architecture with pulmonary pressure and right ventricular dysfunction. Methods and Results: We leveraged Vanderbilt University's deidentified electronic health records and DNA biobank to identify 14 861 subjects of European ancestry who underwent at least 1 echocardiogram with available estimates of pulmonary pressure and right ventricular function. Analyses of the study were performed between 2020 and 2022. The final analytical sample included 14 861 participants (mean [SD] age, 63 [15] years and mean [SD] body mass index, 29 [7] kg/m 2 ). An unbiased phenome‐wide association study identified diabetes as the most statistically significant clinical International Classifications of Diseases , Ninth Revision ( ICD‐9 ) code associated with polygenic risk for increased pulmonary pressure. We validated this finding further by finding significant associations between genetic risk for diabetes and a related condition, obesity, with pulmonary pressure estimate. We then used 2‐sample univariable Mendelian randomization and multivariable Mendelian randomization to show that diabetes, but not obesity, was independently associated with genetic risk for increased pulmonary pressure and decreased right ventricle load stress. Conclusions: Our findings show that genetic risk for diabetes is the only significant independent causative driver of genetic risk for increased pulmonary pressure and decreased right ventricle load stress. These findings suggest that therapies targeting genetic risk for diabetes may also potentially be beneficial in treating pulmonary hypertension and right heart dysfunction.Keywords
This publication has 46 references indexed in Scilit:
- Discovery and refinement of loci associated with lipid levelsNature Genetics, 2013
- Polygenic Modeling with Bayesian Sparse Linear Mixed ModelsPLOS Genetics, 2013
- A high-performance computing toolset for relatedness and principal component analysis of SNP dataBioinformatics, 2012
- Physiologic and molecular consequences of endothelial Bmpr2 mutationRespiratory Research, 2011
- Unrecognized glucose intolerance is common in pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2011
- Plasma Levels of High-Density Lipoprotein Cholesterol and Outcomes in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Understanding cardiovascular disease through the lens of genome-wide association studiesTrends in Genetics, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- The control of the false discovery rate in multiple testing under dependencyThe Annals of Statistics, 2001